Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,183,200 | 1,024,000 | 903,500 | 662,900 | 1,179,100 |
| Marketable Securities | 219,400 | 271,300 | 260,300 | 368,200 | 337,800 |
| Receivables | 602,800 | 671,700 | 567,900 | 585,100 | 599,100 |
| Inventories | 802,300 | 773,300 | 735,100 | 662,200 | 640,900 |
| Other current assets | 208,200 | 171,500 | 166,200 | 163,700 | 168,000 |
| TOTAL | $3,091,000 | $2,980,400 | $2,690,300 | $2,507,900 | $2,984,000 |
| Non-Current Assets | |||||
| PPE Net | 1,395,200 | 1,276,300 | 1,195,600 | 1,100,600 | 1,060,300 |
| Investments And Advances | 801,600 | 599,000 | 594,400 | 587,800 | 585,500 |
| Intangibles | 1,504,600 | 1,502,400 | 1,501,200 | 1,501,000 | 1,504,200 |
| Other Non-Current Assets | 444,700 | 442,700 | 442,600 | 378,800 | 354,100 |
| TOTAL | $4,146,100 | $3,820,400 | $3,733,800 | $3,568,200 | $3,504,100 |
| Total Assets | $7,237,100 | $6,800,800 | $6,424,100 | $6,076,100 | $6,488,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 196,500 | 822,100 | 849,400 | 722,000 | 180,400 |
| Accrued Expenses | 670,200 | N/A | N/A | N/A | 696,500 |
| TOTAL | $893,900 | $846,300 | $873,200 | $746,900 | $902,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 595,000 | 594,900 | 594,700 | 594,600 | 594,400 |
| aiOther Non-Current Liabilities | 1,173,900 | 1,149,300 | 1,117,100 | 833,500 | 843,000 |
| TOTAL | $1,768,900 | $1,744,200 | $1,711,800 | $1,428,100 | $1,437,400 |
| Total Liabilities | $2,662,800 | $2,590,500 | $2,585,000 | $2,175,000 | $2,339,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 624,519 | 623,248 | 621,741 | 619,664 | 627,368 |
| Common Shares | 636,400 | 635,000 | 633,500 | 218,500 | 218,100 |
| Retained earnings | 4,565,000 | 4,255,500 | 3,930,300 | 4,052,200 | 3,741,600 |
| Other shareholders' equity | -161,200 | -157,800 | -145,600 | -151,500 | -155,700 |
| TOTAL | $4,574,300 | $4,210,300 | $3,839,100 | $3,901,100 | $4,148,300 |
| Total Liabilities And Equity | $7,237,100 | $6,800,800 | $6,424,100 | $6,076,100 | $6,488,100 |